Search results
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) is definitely on the radar of institutional investors who...
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM), it is...
NGM Biopharmaceuticals (NGM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 2 years agoNGM Biopharmaceuticals (NGM) possesses the right combination of the two key ingredients for a likely...
Great week for NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) institutional investors after losing 30%...
Simply Wall St. via Yahoo Finance· 2 years agoIf you want to know who really controls NGM Biopharmaceuticals, Inc. (NASDAQ:NGM), then you'll have...
NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) insider upped their holding by 68% earlier this year
Simply Wall St. via Yahoo Finance· 1 year agoLooking at NGM Biopharmaceuticals, Inc.'s (NASDAQ:NGM ) insider transactions over the last year, we...
NGM Biopharmaceuticals (NGM) Soars 6.8%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 2 years agoNGM Biopharmaceuticals (NGM) saw its shares surge in the last session with trading volume being...
NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 months agoNGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 10.81% and 91.75%,...
We Think NGM Biopharmaceuticals (NASDAQ:NGM) Can Afford To Drive Business Growth
Simply Wall St. via Yahoo Finance· 2 years agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
How Much Upside is Left in NGM Biopharmaceuticals (NGM)? Wall Street Analysts Think 462%
Zacks via Yahoo Finance· 1 year agoThe mean of analysts' price targets for NGM Biopharmaceuticals (NGM) points to a 461.7% upside in...
Shareholders in NGM Biopharmaceuticals (NASDAQ:NGM) have lost 42%, as stock drops 6.5% this past...
Simply Wall St. via Yahoo Finance· 2 years agoInvestors can approximate the average market return by buying an index fund. While individual stocks...
NGM Biopharmaceuticals Inc (NGM) Reports Q3 2023 Financial Results
GuruFocus.com via Yahoo Finance· 6 months agoNGM Biopharmaceuticals Inc (NASDAQ:NGM) reported a net loss of $28.8 million for Q3 2023, compared...